Janus kinase inhibitors are effective in atopic keratoconjunctivitis treatment and not only in managing dupilumab-induced ocular adverse events
Year: 2025
Type: article
Source: British Journal of Dermatology
DOI: 10.1093/bjd/ljaf424
Authors: Yasmine Bendoukha, Benjamin Jacob, Marc Muraine, Florence Tétart, Julie Gueudry
Institution: Centre Hospitalier Universitaire de Rouen
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415687271
